purongo

Te painga anticoagulant o te heparin pauna karapoti iti i runga i te niumonia coronary hou

1. Te Taatai ​​me te Maimoatanga mo te COVID-19 (Whakatautau Whakatauranga 8) na National Health Commission o te PRC
Ko te raru o te thromboembolism he teitei ake i nga tuuroro tuukino me te tuukino ranei, ……, Me whakamahi prophylactically nga Anticoagulants. Mena he thromboembolism, me whakatutukihia te rongoa anticoagulant kia rite ki nga aratohu rite.

2. — Ko te mate CELL SARS-CoV-2 ka whakawhirinaki ki te Cellular Heparan Sulphate me te ACE2, ko te Heparin me nga momo kore-anticoagulant te aukati i te hononga SARSCoV-2 me nga mate.

3. Ko te rongoa anake e whakamahia whaaia ana i tenei rohe ko te horopeta aukati o te heparin pauna ngatata iti (LMWH), me whakaaro ki nga tuuroro katoa i te hohipera me te niumonia coronary hou (tae atu ki nga tuuroro kore-nui) kaore he whakapae
He aratohu poto a ISTH mo te mohiotanga me te whakahaere coagulopathy i te COVID-19

Anticoagulant effect of low molecular weight heparin on new coronary pneumonia3

4. I nga tuuroro (pakeke me nga taiohi) i te hohipera me te COVID-19, whakamahia te rongoa rongoa rongoa, penei i te heparin pauna ngota iti (penei i te enoxaparin), e ai ki nga paerewa o te rohe me te ao, hei aukati i te thromboembolism venous, ka kore e whakahee.

Anticoagulant effect of low molecular weight heparin on new coronary pneumonia2

5. Ko nga tuuroro katoa he nui te mate kino o te COVID-19, he iti, he ngawari ranei ki te tupapaku toto, kaore he whakapae ki te whakamahi i nga raau rongoa hei aukati i te VTE, a ko te heparin pauna haumanu iti te mea tuatahi mo te ngoikoretanga nui o te whatukuhu, e taunakitia ana te heparin korekore.
Mo nga tuuroro ngawari me te nuinga, mena he nui te morearea ranei o te VTE, ka taunakihia te aukati rongoa i muri i te whakakorea o nga whakapae, a ko te heparin ngota iti te kowhiringa tuatahi.

Te aukati me te Maimoatanga o te Venombo Thromboembolism e Pa ana ki te Mate Coronavirus 2019 Mate: He Kupu Whakaaetanga i mua o nga Aratohu

Anticoagulant effect of low molecular weight heparin on new coronary pneumonia


Te wa tuku: Tihema-28-2020